Medical Affairs Reports Findings in Depression (Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan): Mental Health Diseases and Conditions – Depression – InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Life Insurance News
    • Annuity News
    • Health/Employee Benefits
    • Property and Casualty
    • Advisor News
    • Washington Wire
    • Regulation News
    • Sponsored Articles
    • Monthly Focus
  • INN Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
Sign in or register to be an INNsider.
  • Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
  • Insider Pro
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Newsletters

Get Social

  • Facebook
  • Twitter
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
September 26, 2022 Newswires No comments
Share
Share
Tweet
Email

Medical Affairs Reports Findings in Depression (Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan): Mental Health Diseases and Conditions – Depression

Health & Medicine Business Daily

2022 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily -- New research on Mental Health Diseases and Conditions - Depression is the subject of a report. According to news reporting out of Taipei, Taiwan, by NewsRx editors, research stated, “Determining the proportion of patients with treatment-resistant depression (TRD) among patients with unipolar depression receiving adequate pharmacological treatment (pharmaceutically treated depression [PTD]) is clinically important and may affect health care utilization. In Taiwan, these issues can be assessed by analyzing population-based data.”

Our news journalists obtained a quote from the research from Medical Affairs, “The present study included data from the Taiwan National Health Insurance Research Database from 2010 to 2017. Among patients with depression, PTD was defined by the receipt of at least one adequate antidepressant treatment, and TRD was defined as receiving a third adequate antidepressant treatment after failure to respond to two prior treatments. Time of progression from PTD to TRD was estimated via the Kaplan-Meier function. A propensity-matched case-comparison cohort approach was used to compare resource utilization between patients with non-TRD PTD and TRD. TRD was defined in 11.2 % of patients with unipolar depression and 37.1 % of PTD patients. The time of progression from PTD to TRD was approximately 1 year. Most TRD patients were women, middle-aged, and treated in general practice clinics. Antidepressant monotherapy, followed by antidepressant with augmentation, was the most common treatment strategy applied to TRD patients. Medical utilization was significantly higher in patients with TRD than those with non-TRD PTD across most aspects. TRD was defined based on pharmacological treatment patterns, as the reasons for changes in antidepressant regimens were not available. Approximately one-third of patients with PTD developed TRD, often soon after receiving adequate pharmacological treatment.”

According to the news editors, the research concluded: “Patients with TRD used more medical resources than patients with non-TRD PTD.”

Related stories

  • South Dakota farmers sentenced for crop insurance, relief fraud
  • Founder of purported crypto company sentenced to over 8 years for fraud

This research has been peer-reviewed.

For more information on this research see: Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan. Journal of Affective Disorders, 2022. Journal of Affective Disorders can be contacted at: Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands. (Elsevier - www.elsevier.com; Journal of Affective Disorders - http://www.journals.elsevier.com/journal-of-affective-disorders/)

Our news journalists report that additional information may be obtained by contacting Chih-Lin Chiang, Medical Affairs, Janssen Pharmaceutical of Johnson & Johnson, Taipei City 104, Taiwan. Additional authors for this research include Wei-Lieh Huang, Chi-Shin Wu, Shih-Cheng Liao, Tzu-Hsiang Chien, Chiung-Hui Tseng and Chao-Hsiun Tang.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.jad.2022.08.114. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the Journal of Affective Disorders is: Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands.

(Our reports deliver fact-based news of research and discoveries from around the world.)

Older

Hurricane Ian Live Updates: Tornado threat a concern in Central Florida [Orlando Sentinel]

Newer

Hurricane Ian Live Updates: First time homeowners fret over Ian [Orlando Sentinel]

Advisor News

  • 12 ways SECURE 2.0 can benefit your clients
  • Republicans, Joe Manchin set sights on tanking Biden's climate friendly 401(k) rules
  • For agents and advisors, dispelling LTCI myths is crucial to building sales
  • Several major changes with Social Security expected to come in 2023
  • Some major REITs limiting cash-out requests from investors
More Advisor News

Annuity News

  • Sweet streams of income: ChatGPT, the bard of annuities
  • F&G Annuities & Life announces equity investment in life IMO SYNCIS
  • Investors scrambling to lock in rates propel annuity sales to record highs
  • North American and Annexus launch new fixed index annuity
  • Producers stew as insurers slow to process life and annuity applications
Sponsor
More Annuity News

Health/Employee Benefits News

  • Ohio physician pleads guilty to illegally prescribing opiods, healthcare fraud
  • Affordable Care Act's no-cost contraception rule would be bolstered under Biden move
  • Medicare Advantage open enrollment is happening now
  • Medicaid coverage is expiring for millions of Americans – but there's a proven way to keep many of them insured
  • Health savings account balances increase in 2021
More Health/Employee Benefits News

Life Insurance News

  • House approves bill protecting life insurance payouts from bankruptcy
  • NAIFA’s Future Leaders Program offers free sessions for students
  • Scott Boutin named president of Standard Security Life
  • Agent insists Alex Murdaugh suggested he killed his son
  • 78% of families suffer financially handling estate affairs
More Life Insurance News
The time is 06:11:15pm test

- Presented By -

Top Read Stories

  • Investors scrambling to lock in rates propel annuity sales to record highs
  • Chicago news roundup: PPP fraud uncovered in Chicago, informant reveals $100K bounty on FBG Duck and more
  • For some, nothing to fear from taking RMDs, professor says
  • Study: Education level should drive decisions on Social Security, annuities
  • Maine man sentenced to 33 months for fraudulently receiving PPP funds
More Top Read Stories >

FEATURED OFFERS

Meet Encova Life
We know agents matter. You can count on our life team to be high tech, high touch and responsive.

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty
  • Advisor News
  • Washington Wire
  • Regulation News
  • Sponsored Articles
  • Monthly Focus

Top Sections

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits News
  • Property and Casualty News
  • AdvisorNews
  • Washington Wire
  • Insurance Webinars

Our Company

  • About
  • Editorial Staff
  • Magazine
  • Write for INN
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2023 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • AdvisorNews

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.